McCamish Mark Anthony 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Aug 1, 2024
Insider Transaction Report
Form 4
McCamish Mark Anthony
Director
Transactions
- Award
Ordinary Shares
2024-07-30+11,000→ 11,000 total - Award
Stock Option (Right to Buy)
2024-07-30+11,000→ 11,000 totalExercise: $16.32Exp: 2034-07-30→ Ordinary Shares (11,000 underlying)
Holdings
- 67,025(indirect: By LLC)
Ordinary Shares
Footnotes (3)
- [F1]Represents restricted share units ("RSUs"). Each RSU represents the contingent right to receive one Ordinary Share upon vesting and settlement. The RSUs shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.
- [F2]Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager.
- [F3]The options shall vest in full on the earlier to occur of (a) July 30, 2025 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.